




Geoffrey North is editor of Current
Biology, a journal he has worked on
since April 1992. Before that he
was deputy biology editor of
Nature, where he had worked since
February 1981. That is his full
employment history.
What attracted you to science
editing? Complete chance. Having
recently abandoned a PhD, on the
grounds of hopeless
incompetence, I was at home when
I received a phone call from the
deputy editor of Nature, Peter
Newmark, asking if I would like to
come and work there as a locum,
to cover for the sabbatical absence
of Miranda Robertson, a senior
member of the biology team; they
knew of my availability via contacts
at Cambridge University, where I
had studied biochemistry as an
undergraduate. I was kept on to
cover for Peter Newmark’s
sabbatical in the summer of 1981,
during which time another member
of the team, Mary Lindley, died; I
got her job and considered myself
extremely lucky to have a
permanent position on Nature.
So why did you leave Nature in
1992? The short answer is that,
when Miranda Robertson, by then
biology editor of Nature, resigned, I
did not want to apply for the job
and felt it would be a good time for
me to move on. As it happens,
Peter Newmark had left a couple of
years earlier and, together with
Vitek Tracz, invented Current
Biology. In its first form, the journal
just published short biology news
stories — the dispatches which we
still publish — a format very clearly
modelled on Nature’s News and
Views section. But it seemed to me
that Peter and Vitek had improved
on that — very successful —
formula, particularly with the
computer-drawn full colour
illustrations which at the time were
a real innovation. The editorship of
Current Biology had just become
available — another lucky
coincidence — and once again a
phone conversation with Peter
Newmark did the trick and I moved
from Nature to Current Biology.
Do you have a favourite among
the papers you were involved
with at Nature? A number come
to mind. By 1982, the days of the
truly great papers in genetics and
molecular biology were already
over; we were into the era of
‘revelation’, where cloning and
sequencing were providing great,
but in a sense easy, insights. One
paper I found very exciting was the
one from Walter Gehring’s lab that
reported the first hint as to the
existence of the homeobox
(McGinnis et al. ‘A conserved DNA
sequence in homeotic genes of the
Drosophila Antennapedia and
bithorax complexes’, Nature 1984,
308, 428-433). Disappointingly, the
key follow-up papers, reporting the
homeobox amino-acid sequence
and, most excitingly at the time, its
conservation in vertebrates, were
not offered to us, but published in
Cell. We did, however, publish an
important paper from Gines Morata
and colleagues (Sanchez-Herrero
et al. ‘Genetic organization of the
Drosophila bithorax complex’,
Nature 1985, 313, 108-113),
reporting evidence that the
bithorax complex has three genes,
corresponding to the three
molecularly identified homeoboxes.
Similar revelations came thick
and fast in the early 1980s —
perhaps the most exciting came
when cellular oncogenes were
cloned and sequenced, and found
to encode subtly modified versions
of normal cellular proteins involved
in the regulation of cell
proliferation. Immunology was also
taking great strides and Nature
published many of the key papers,
such as those reporting the cloning
of T-cell receptor genes and the
structures of MHC protein
complexes with antigenic peptides;
at the beginning of the 1980s,
‘antigen presentation’ by T
lymphocytes was a great mystery,
by the end of the decade, the basic
mechanisms had become clear.
And what was your biggest
mistake? I am not certain that it
was specifically my mistake, but I
was part of the team that made the
decision: this is Nature’s much-
rumoured rejection of one of the
papers that led to the Nobel-prize-
winning determination of the
structure of a photosynthetic
reaction centre complex. What we
actually turned down was, not the
paper reporting structure itself, but
rather a short report of the
crystallization of the complex. We
did so, because by the early 1980s
papers reporting crystallizations
were deemed not appropriate for
Nature; they usually came out as
technical notes in the specialist
literature  — as did this one (Michel
H., J. Mol. Biol. 1982, 158, 567-572).
Was it a mistake? That is certainly
arguable, but in retrospect I think it
was: we should have appreciated
that crystallization was a key
limiting step in structure
determination, and for a membrane
protein complex of this kind, to
make crystals was a real
breakthrough. 
As it happens, Nature did publish
one of the two key papers
publishing the actual structure: the
first, reporting the arrangement of
the chromophores, was never
offered to Nature and came out
elsewhere (Deisenhofer et al. J.
Mol. Biol. 1984, 180, 385-398); but
the paper reporting the structure of
the protein part of the complex was
submitted to Nature and duly
accepted and published
(Deisenhofer et al. Nature 1985,
318, 618-624).
Is your job now very different
from that at Nature in the
1980s? Most definitely, at least in
terms of procedure. When I left
Nature, we were just finalising the
specifications for the use of
computers. It seems extraordinary
now to think we did this job without
computers, no email, no internet.....
Papers were just sent off by
ordinary mail to reviewers without
knowing that they were there, or
even alive (sometimes they
weren’t), let alone whether they
were willing to assess the paper. It
is no wonder that decisions often
took so long. The internet is, one
has to admit, a godsend for editors.
As to my job specifically: some
things don’t change much, but it is
good to be heavily involved in the
editorial sections of the journal, as
well the peer review of primary
papers; and I have to admit, it is
good to be the editor, and (usually)
to have the last word ....
Do you have any scientific
heroes? Many. Charles Darwin is
— quite rightly — a hero for many
in biology. He is undoubtedly the
greatest biologist of all time; I think
many may also envy the way he
was able to work at home, with a
lifestyle rather similar to that of a
country parson, surrounded by his
family. What continues to astonish
is the way that he has turned out to
be right on so many fundamental
issues. I became aware of the
immense contributions of another
member of my personal pantheon,
Theodor Boveri, only recently,
when I heard Eric Wieschaus talk
about his great work leading to the
chromosomal theory of inheritance,
and his remarkably prescient
insights into the role differential
genome expression plays in
development. I also have another
set of unsung heroes — these are
biologists who are excellent
referees, not just for a short period
early in their careers, but for many
years, offering prompt, sage advice
even when they are very senior. I
can think of a number of
outstanding examples, but it would
probably be invidious to name
names here.
What advice would you offer a
beginning editor on a biology
journal? That might be a bit
presumptuous, but never mind....
Firstly, in my view, there are no
hard and fast rules about the
process of choosing papers for
publication in a general journal.
Secondly, it is easy to think of
reasons not to publish something
— the greater ability, in my view, is
in appreciating why something
might be interesting and important
when it is not entirely obvious, or
worth publishing despite
imperfections. Thirdly, bear in mind
that you have responsibilities to
your contributors (authors) as well
as your readers. And lastly, the
most critical referee is not
necessarily right.
What is the role of a general
journal? I think a general journal
such as Current Biology has
several distinct roles. One obvious
one is the publication of papers
with some claim to be of interest to
readers in different disciplines. I
strongly believe that an important
function of Current Biology is to
facilitate communication across
the disciplines in biology — and
particularly between the two main
wings, the molecular and the non-
molecular. A glance at Current
Biology would probably give the
impression we are dominated by
the molecular aspects of biology —
this would be fair comment, and I
think essential to be a really
‘important’ journal these days. But
we also try to cover important
developments in the non-molecular
fields, such as psychology,
evolutionary biology and ecology.
What we hope to do is to draw
people’s attention to interesting
work in other fields, both by
publication of papers and via our
— unapologetically didactic —
editorial sections. My belief is that
the barriers between the
subdisciplines of biology are, very
gradually, declining, so that general
journals are becoming increasingly
important. 
Another important, related but
distinct function is that general
journals act as a filter: ideally, we
publish the ‘best’ papers, reporting
the stories most likely to be a wide
interest, and those with the
greatest claim to coverage in the
general media (newspapers,
television and so on). A hierarchy
of journals, with the general ones at
the ‘top’, helps journalists to find
reports of the most significant
developments — those that are of
most interest, and also
(importantly) ‘sound’, in the sense
of having passed rigorous peer
review. In this sense, general
journals offer a link between the
specialist scientific literature and
the general media and public.
What do you think are the most
interesting developments in
biology at the moment? One is
the increasing interest in
quantitative theory — I wrote about
this in a recent editorial ‘Biophysics
and the Place of Theory in Biology’
(Curr. Biol. 13,  R719-R720). In
general I think this is a good thing
— to understand many phenomena
properly, it seems obvious that
quantification and theory will be
needed. That said, there are many
contentious aspects to biological
theorising, touched on in our new
magazine essay series ‘Theory in
Biology’ — see, for example, Peter
Lawrence’s essay ‘Theoretical
embryology: a route to extinction?’
(Curr. Biol. 14, R7-R8). There will no
doubt be ‘noise’ generated — it is
harder to tell whether a theoretical
contribution will be of long-lasting
importance than is generally the
case for experimental studies. An
object lesson is provided by
theoretical neurobiology, where in
artificial intelligence and neural
network modelling it seems there
are waves of hype and expectation,
followed by disillusion — one only
has to consider all the fuss about
parallel distributed processing in
the 1980s (see Francis Crick’s 1989
article ‘The recent excitement
about neural networks’, Nature
337, 129-132). But I don’t think
anyone can seriously argue that we
shall be able to understand
something as complex as the brain
without a theoretical framework.
Anything else? Yes. Invertebrate
neurobiology seems to have
entered an exciting phase, with
great opportunities offered by new
techniques for manipulating the
activities of small, defined groups
of neurons. I think we shall see a
lot of progress here in
understanding neural circuits and
the neural basis of learning and
behaviour. The genetic analysis of
complex phenomena, such as
circadian rhythms, is advancing
apace. New model species are
emerging; a number of these have
been subjects for our Quick Guide
columns — for example, a recent
one considered sticklebacks (Curr.
Biol. 13, R942-R943), and more are
in the pipeline. I think genomics
has reached the point of being
‘just’ another technique, but it is
certainly providing a huge input of
new data for evolutionary studies,
with some very interesting results. I
have a feeling that studies of
animal cognition are going to be
interesting and informative in
coming years. While one might
look back wistfully on the ‘classical
era’ of molecular biology, when the
essential nature of the information
systems common to all cells was
elucidated, to my mind biology is
still a most exciting and fascinating
field of study.
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